DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $272

Wells Fargo maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $270 to $272.

Benzinga · 01/31/2020 13:29

Wells Fargo maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $270 to $272.